TABLE 3.
Bile Acid | Human Serum | Rat Serum | Mouse Serum |
CA | 440 ± 651 | 12,000 ± 5,600 | 1,240 ± 450 |
αMCA | <LODa | 2,800 ± 1,300 | 142 ± 95 |
βMCA | <LOD | 2,600 ± 2,700 | 1,080 ± 550 |
ωMCA | <LOD | 1,360 ± 700 | 1,450 ± 970 |
HCA | 24 ± 19 | 78 ± 31 | 15 ± 12 |
CDCA | 380 ± 410 | 1,700 ± 600 | 42 ± 23 |
DCA | 320 ± 120 | 420 ± 250 | 390 ± 220 |
UDCA | 43 ± 27 | 200 ± 120 | 74 ± 45 |
HDCA | <LLOQb | 230 ± 130 | 58 ± 31 |
MuroCA | <LOD | 45 ± 20 | 45 ± 21 |
LCA | <LOD | 54 ± 33 | 22 ± 11 |
DHCA | <LOD | <LOD | <LOD |
GCA | 85 ± 55 | 730 ± 500 | 3.5 ± 0.5 |
GHCA | 6.8 ± 3.3 | 0.13 ± 0.35 | <LOD |
GCDCA | 450 ± 210 | 74 ± 33 | 0.08 ± 0.20 |
GDCA | 104 ± 44 | 48 ± 27 | <LOD |
GUDCA | 76 ± 40 | 4.1 ± 1.9 | <LOD |
GHDCA | 2.1 ± 3.4 | 8.1 ± 4.0 | <LOD |
GLCA | 17 ± 20 | 2.3 ± 1.5 | 0.42 ± 0.49 |
GDHCA | <LOD | <LOD | <LOD |
TCA | 14 ± 12 | 660 ± 390 | 260 ± 110 |
TαMCA | 2.9 ± 2.7 | 150 ± 210 | 102 ± 46 |
TβMCA | <LOD | 160 ± 170 | 230 ± 140 |
TωMCA | <LLOQ | 18 ± 11 | 290 ± 170 |
THCA | 1.3 ± 1.1 | 1.44 ± 0.62 | 2.8 ± 2.7 |
TCDCA | 69 ± 56 | 118 ± 73 | 12.3 ± 7.0 |
TDCA | 21 ± 18 | 40 ± 21 | 55 ± 23 |
TUDCA | 2.7 ± 2.7 | 6.9 ± 5.3 | 17 ± 12 |
THDCA | <LOD | 16.1 ± 6.3 | 18.8 ± 7.7 |
TLCA | 0.33 ± 0.52 | 2.5 ± 1.4 | 0.33 ± 0.61 |
TDHCA | <LOD | <LOD | <LOD |
Nonconjugated | 1,200 ± 1,100 | 22,000 ± 11,000 | 4,600 ± 2,300 |
Glycine-conjugated | 740 ± 310 | 870 ± 550 | 4.08 ± 0.80 |
Taurine-conjugated | 110 ± 88 | 1,480 ± 760 | 990 ± 500 |
Total | 2,100 ± 1,100 | 24,000 ± 11,000 | 5,500 ± 2,800 |
The results are expressed in nM as mean ± SD (n = 8).
Under the limit of detection.
Under the limit of quantification.